Translation of a human induced pluripotent stem cell-derived ovarian support cell product to a Phase 3 enabling clinical grade product for in vitro fertilization treatment
Bruna Paulsen, Ferran Barrachina, Sabrina Piechota, Alexander D. Noblett, Mark Johnson, Simone Kats, Cassandra Lew, Maria Marchante, Alexandra B. Figueroa, Itzel Garcia Granada, Elizabeth Ingalls Lopez, Erick Martinez Martinez, Paula Ricra, Camila Carlos, Jazmin Meza, Wendy Montanchez, Pilar Pino, Cesar Reategui, Enrique Noriega, Alicia Elias, Luis Noriega-Portella, Gus Haddad, Dina Radenkovic, Eugenia Moran, Pamela Villanueva, Jose Guiterrez, Luis Guzman, Pietro Bortolleto, David F. Albertini, Michel De Vos, Christian C. Kramme
doi: https://doi.org/10.1101/2025.04.02.25324702
Bruna Paulsen
1Gameto Inc. New York, New York, United States
Ferran Barrachina
1Gameto Inc. New York, New York, United States
Sabrina Piechota
1Gameto Inc. New York, New York, United States
Alexander D. Noblett
1Gameto Inc. New York, New York, United States
Mark Johnson
1Gameto Inc. New York, New York, United States
Simone Kats
1Gameto Inc. New York, New York, United States
Cassandra Lew
1Gameto Inc. New York, New York, United States
Maria Marchante
1Gameto Inc. New York, New York, United States
Alexandra B. Figueroa
1Gameto Inc. New York, New York, United States
Itzel Garcia Granada
2Fertilidad Integral, Mexico City, Mexico
Elizabeth Ingalls Lopez
2Fertilidad Integral, Mexico City, Mexico
Erick Martinez Martinez
2Fertilidad Integral, Mexico City, Mexico
Paula Ricra
3Pranor Clinic, Lima, Peru
Camila Carlos
3Pranor Clinic, Lima, Peru
Jazmin Meza
3Pranor Clinic, Lima, Peru
Wendy Montanchez
3Pranor Clinic, Lima, Peru
Pilar Pino
3Pranor Clinic, Lima, Peru
Cesar Reategui
3Pranor Clinic, Lima, Peru
Enrique Noriega
3Pranor Clinic, Lima, Peru
Alicia Elias
3Pranor Clinic, Lima, Peru
Luis Noriega-Portella
3Pranor Clinic, Lima, Peru
Gus Haddad
1Gameto Inc. New York, New York, United States
Dina Radenkovic
1Gameto Inc. New York, New York, United States
Eugenia Moran
2Fertilidad Integral, Mexico City, Mexico
Pamela Villanueva
3Pranor Clinic, Lima, Peru
Jose Guiterrez
2Fertilidad Integral, Mexico City, Mexico
Luis Guzman
3Pranor Clinic, Lima, Peru
Pietro Bortolleto
4Boston IVF, Boston, Massachusetts, United States
David F. Albertini
5Bedford Research Foundation, Bedford, MA, United States
Michel De Vos
6Brussels IVF, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium
Christian C. Kramme
1Gameto Inc. New York, New York, United States

- Supplementary Figures[supplements/324702_file03.docx]
- Supplementary Tables[supplements/324702_file04.xlsx]
Posted April 05, 2025.
Translation of a human induced pluripotent stem cell-derived ovarian support cell product to a Phase 3 enabling clinical grade product for in vitro fertilization treatment
Bruna Paulsen, Ferran Barrachina, Sabrina Piechota, Alexander D. Noblett, Mark Johnson, Simone Kats, Cassandra Lew, Maria Marchante, Alexandra B. Figueroa, Itzel Garcia Granada, Elizabeth Ingalls Lopez, Erick Martinez Martinez, Paula Ricra, Camila Carlos, Jazmin Meza, Wendy Montanchez, Pilar Pino, Cesar Reategui, Enrique Noriega, Alicia Elias, Luis Noriega-Portella, Gus Haddad, Dina Radenkovic, Eugenia Moran, Pamela Villanueva, Jose Guiterrez, Luis Guzman, Pietro Bortolleto, David F. Albertini, Michel De Vos, Christian C. Kramme
medRxiv 2025.04.02.25324702; doi: https://doi.org/10.1101/2025.04.02.25324702
Translation of a human induced pluripotent stem cell-derived ovarian support cell product to a Phase 3 enabling clinical grade product for in vitro fertilization treatment
Bruna Paulsen, Ferran Barrachina, Sabrina Piechota, Alexander D. Noblett, Mark Johnson, Simone Kats, Cassandra Lew, Maria Marchante, Alexandra B. Figueroa, Itzel Garcia Granada, Elizabeth Ingalls Lopez, Erick Martinez Martinez, Paula Ricra, Camila Carlos, Jazmin Meza, Wendy Montanchez, Pilar Pino, Cesar Reategui, Enrique Noriega, Alicia Elias, Luis Noriega-Portella, Gus Haddad, Dina Radenkovic, Eugenia Moran, Pamela Villanueva, Jose Guiterrez, Luis Guzman, Pietro Bortolleto, David F. Albertini, Michel De Vos, Christian C. Kramme
medRxiv 2025.04.02.25324702; doi: https://doi.org/10.1101/2025.04.02.25324702
Subject Area
Subject Areas
- Addiction Medicine (427)
- Allergy and Immunology (753)
- Anesthesia (220)
- Cardiovascular Medicine (3285)
- Dermatology (276)
- Emergency Medicine (478)
- Epidemiology (13347)
- Forensic Medicine (19)
- Gastroenterology (898)
- Genetic and Genomic Medicine (5139)
- Geriatric Medicine (480)
- Health Economics (781)
- Health Informatics (3260)
- Health Policy (1140)
- Hematology (429)
- HIV/AIDS (1015)
- Medical Education (476)
- Medical Ethics (126)
- Nephrology (522)
- Neurology (4911)
- Nursing (262)
- Nutrition (725)
- Oncology (2517)
- Ophthalmology (722)
- Orthopedics (280)
- Otolaryngology (347)
- Pain Medicine (323)
- Palliative Medicine (90)
- Pathology (542)
- Pediatrics (1299)
- Primary Care Research (555)
- Public and Global Health (7489)
- Radiology and Imaging (1703)
- Respiratory Medicine (979)
- Rheumatology (479)
- Sports Medicine (424)
- Surgery (547)
- Toxicology (72)
- Transplantation (235)
- Urology (203)